Quidel

The GenomeWeb Index fared better than its benchmark counterparts in March, but still fell more than 4 percent.

Now, the assay can also be used with the Applied Biosystems 7500 Standard from Thermo Fisher Scientific, Roche's LightCycler 480, and Qiagen's Rotor-Gene Q.

The EUA is the fifth in less than a week from the FDA for assays to detect SARS-CoV-2 as testing capacity in the US continues to ramp up.

The firm reports it had the highest flu revenue in the fourth quarter since the pandemic flu outbreak of 2009.

Exact Sciences CEO Kevin Conroy discussed the firm's pipeline and plans for 2020 and beyond, while NanoString CEO Brad Gray talked about the company's GeoMx digital spatial profiling technology, among other presentations Wednesday.

Quidel said that it expects fourth quarter 2019 revenues to be in the range of $151 million to $152 million, which would eclipse analyst expectations.

The firm saw a 36 percent increase in influenza product sales compared to the third quarter last year.

The FDA-cleared panel includes tests for salmonella, Shiga toxin-producing Escherichia coli, Shigella, Campylobacter, and Cryptosporidium.

The index, which slightly underperformed the Dow Jones, had a smaller loss in August than in the previous month.